ESR1 and breast neoplasm: To assess the clinical relevance of our findings, we analyzed RNA-Seq data from human breast tumors in The Cancer Genome Atlas (TCGA) collection6, which revealed higher ID1 and ID3 mRNA expression in both ER-positive and LumA ILC versus IDC tumors (Fig. 7a).